• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Seres Therapeutics - Articles and news items

Nestlé Health Science and Seres collaborate on Ecobiotics

Industry news / 12 January 2016 / Victoria White

Nestlé Health Science has signed an exclusive agreement outside the US and Canada for Seres Therapeutics’ Ecobiotics in clostridium difficile infections and inflammatory bowel disease…

First patient dosed in the Phase 2 study of SER-109 in recurrent Clostridium difficile infection

Industry news / 28 May 2015 / Victoria White

Seres Therapeutics has enrolled and dosed the first patient in its Phase 2 clinical study of SER-109 in recurrent CDI in adults…